Table 1 Results of clinical tests performed on Day 0 and Day 14.
Parameters | Control (N = 8) | Treatment (N = 8) | Control vs. treatment on day 14 | ||
|---|---|---|---|---|---|
Day 0 | Day 14 | Day 0 | Day 14 | P | |
Systolic blood pressure (mmHg) | 111 ± 22 | 109 ± 32 | 137 ± 21 | 130 ± 24 | 0.170 |
Diastolic blood pressure (mmHg) | 83 ± 18 | 59* ± 23 | 95 ± 21 | 81 ± 21 | 0.072 |
Pulse pressure(mmHg) | 28 ± 13 | 50** ± 12 | 42 ± 14 | 49 ± 13 | 0.896 |
Heart rate(beats/min) | 122 ± 27 | 138 ± 20 | 105 ± 13 | 109 ± 35 | 0.059 |
pH | 7.465 ± 0.060 | 7.390* ± 0.051 | 7.502 ± 0.049 | 7.380** ± 0.029 | 0.653 |
pCO2 (mmHg) | 45.6 ± 7.4 | 32.9** ± 2.9 | 41.0 ± 8.4 | 33.6* ± 3.2 | 0.682 |
pO2 (mmHg) | 87.4 ± 13.2 | 78.3 ± 8.8 | 85.3 ± 11.3 | 90.8 ± 14.4 | 0.055 |
Base excess (mmol/L) | 8.6 ± 2.2 |  − 4.8** ± 4.3 | 8.6 ± 3.5 |  − 5.1** ± 2.5 | 0.835 |
Bicarbonate (mmol/L) | 32.5 ± 2.2 | 20.2** ± 3.5 | 31.7 ± 3.8 | 19.9** ± 2.3 | 0.863 |
Urea nitrogen (mg/dL) | 6.9 ± 1.9 | 91.8** ± 18.8 | 7.6 ± 2.2 | 102.6** ± 29.7 | 0.402 |
Creatinine (mg/dL) | 0.9 ± 0.1 | 11.7** ± 1.6 | 0.9 ± 0.1 | 9.3** ± 1.2 | 0.005 |
Potassium (mmol/L) | 3.6 ± 0.2 | 5.8** ± 0.7 | 3.8 ± 0.2 | 6.6** ± 0.8 | 0.084 |
Calcium (mg/dL) | 11.0 ± 0.4 | 11.1 ± 1.0 | 10.7 ± 0.4 | 12.0** ± 1.0 | 0.108 |
Phosphorus (mg/dL) | 5.9 ± 0.5 | 16.0** ± 6.2 | 5.5 ± 0.7 | 11.4** ± 2.4 | 0.070 |
Calcium phosphorus product (mg2/dL2) | 65.5 ± 7.8 | 173.7** ± 54.4 | 58.2 ± 7.1 | 135.1** ± 27.2 | 0.094 |
Magnesium (mg/dL) | 1.90 ± 0.08 | 2.03 ± 0.30 | 2.00 ± 0.29 | 2.38 ± 0.19 | 0.058 |
1,25-dihydroxy Vitamin D3 (pg/mL) | 643 ± 210 | 66** ± 18 | 896 ± 345 | 81** ± 28 | 0.213 |
Whole parathyroid Hormone (pg/mL) | 4.1 ± 3.8 | 92.9** ± 61.6 | 7.8 ± 8.4 | 60.1** ± 21.8 | 0.178 |
Kt/V | N.A | 1.92 ± 0.40 | N.A | 2.09 ± 0.92 | 0.640 |